GeneDx Holdings (WGS) Operating Leases (2022 - 2026)

GeneDx Holdings (WGS) has 5 years of Operating Leases data on file, last reported at $66.3 million in Q1 2026.

• Operating Leases for Q1 2026 came in at $66.3 million, up 10.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $66.3 million (up 10.7% YoY), and the FY2025 annual result was $56.0 million, down 12.78% from the prior year.
• Operating Leases advanced to $66.3 million in Q1 2026 per WGS's latest filing, from $56.0 million in the prior quarter.
• Over five years, Operating Leases peaked at $66.3 million in Q1 2026 and troughed at $56.0 million in Q4 2025.
• A 5-year average of $61.4 million and a median of $62.0 million in 2024 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2023 and 2025: Operating Leases rose 11.14% in 2023, then slipped 12.78% in 2025.
• A 5-year view of Operating Leases shows it stood at $60.0 million in 2022, then advanced by 4.87% to $62.9 million in 2023, then grew by 2.09% to $64.3 million in 2024, then retreated by 12.78% to $56.0 million in 2025, then gained by 18.35% to $66.3 million in 2026.
• Business Quant data shows WGS's Operating Leases at $66.3 million in Q1 2026, $56.0 million in Q4 2025, and $57.2 million in Q3 2025.